Patients with multiple myeloma need new therapeutic targets. The authors identify the transmembrane receptor LILRB1 as a potential target as it protects myeloma cells from ferroptosis by facilitating cholesterol uptake and maintaining cholesterol homeostasis and squalene levels.
- Miao Xian
- Qiang Wang
- Qing Yi
